Dr Reddys Laboratories Share Price Today - Live Blog for June 23, 2025

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,317.00. Investors should examine the factors driving this decline. The stock's PE ratio is 19.5600, whereas the industry PE ratio stands at 34.0682.

Dr Reddys Laboratories Ltd observed a -0.06% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,316.45. The stock has a PE ratio of 19.5600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is facing a -0.15% decline and is currently trading at ₹1,317.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced a -0.03% slump and is currently trading at ₹1,318.95. While the stock maintains a PE ratio of 19.5600, the industry PE is 34.0682, raising questions about valuation.

Dr Reddys Laboratories Ltd experienced a -0.13% dip in its share price and is currently trading at ₹1,319.35. The stock has a PE ratio of 19.5600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a -0.07% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,320.55. Investors should examine the factors driving this decline. The stock's PE ratio is 19.5600, whereas the industry PE ratio stands at 34.0682.

With a -0.03% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,320.05. Investors should examine the factors driving this decline. The stock's PE ratio is 19.5600, whereas the industry PE ratio stands at 34.0682.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.13%, reaching a current market price of ₹1,319.80. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd observed a remarkable 0.03% surge in its share price and is presently trading at ₹1,321.80. The increased investor interest is driving this surge.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.14% recently. As of now, this stock is actively trading at a current market price of ₹1,321.35 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.11%, reaching a current market price of ₹1,319.40. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Following a noteworthy 0.04% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,321.35. When it comes to valuation, this stock has a PE ratio of 19.5600, with the industry PE ratio at 34.0682.

Dr Reddys Laboratories Ltd stock price decreased by -0.05%, with the current market value at ₹1,320.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.11% upswing, and it's currently trading at ₹1,321.75 per share. Investors are closely watching this development.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.11%, reaching the current market price of ₹1,321.75. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.11%. At this moment, it's actively trading at ₹1,321.75, presenting an enticing opportunity for those in the market.

With a -0.03% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,321.75. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.5600, while the industry PE is 34.0682.

Dr Reddys Laboratories Ltd witnessed a notable 0.26% surge in its share price and is presently trading at ₹1,322.15, captivating the attention of market participants.

Dr Reddys Laboratories Ltd witnessed a substantial 0.23% increase in its share price and is currently trading at ₹1,317.25. This remarkable performance has caught the eye of investors.

After a notable 0.03% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,314.20. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.33% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,313.85 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.71%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,312.30 per share.

The stock of Dr Reddys Laboratories Ltd suffered a -0.11% decline, and it currently trades at ₹1,302.65 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd experienced a -0.32% slump and is currently trading at ₹1,304.40. While the stock maintains a PE ratio of 19.5600, the industry PE is 34.0682, raising questions about valuation.

Dr Reddys Laboratories Ltd's stock has surged by 0.15%, and it is currently trading at ₹1,309.75. Additionally, the stock maintains a PE ratio of 19.5600, while the industry PE is 34.0682.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.31%, reaching a current market price of ₹1,311.05. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a notable 1.62% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,212.35. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.